Curanex Pharmaceuticals (CURX)
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflam...
- Open
- 5.770
- High
- 6.000
- Low
- 4.600
- Prev. Close
- 5.408
- Volume
- 109.31K
- Turnover
- 585.88K
- Avg Price
- 5.360
- Bid/Ask Ratio
- 0.00%
- Amplitude
- 25.89%
- 52wk High
- 183.592
- Volume Ratio
- 1.25
- Turnover Ratio
- 24.04%
News
- Global Report · 1 hour ago
Genmab's USD 1.2 Billion Revenue Surge Contrasts With FMC's Pivot in Tactical Market Shuffle
- Global Report · 1 hour ago
Healthcare Divergence: Curia Restructures Over USD 1B Debt as Genmab Preps Late-Stage Oncology Pipeline
- Price Alert · 2 hours ago
Pre-market hot trades in US stocks: PicoCELA pre-market down 10.72%; Curanex Pharmaceuticals pre-market down 10.44%
- TradingView · Aug 14 at 11:21 AM
Curanex Pharmaceuticals Inc Q2 2026: Net income $(3.29M), EPS $(0.12) — 10-Q Summary
- PUBT · Aug 14 at 11:16 AM
Curanex net loss widens to $3.29 million in Q2 FY26; no revenue
- benzinga_article · Aug 5 at 07:05 AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
